Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1364 (LINC01364)

Target
LINC01364
Molecular classification
Long non-coding RNA (lncRNA), specifically long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 1364 (LINC01364) is a long non-coding RNA (lncRNA) gene that produces RNA transcripts longer than 200 nucleotides and does not overlap with annotated protein-coding genes[1][3][7]. LINC01364 belongs to the subclass of lncRNAs called long intergenic non-coding RNAs (lincRNAs), which are thought to act as regulators at the transcriptional, post-transcriptional, or epigenetic level, although the precise function of LINC01364 itself has not yet been characterized in the literature[1][3][5]. LINC01364 has been listed among genetic candidates in studies relating to neurodevelopmental disorders such as ADHD, but no clear mechanistic or disease associations have been established to date, nor has it been confirmed as a therapeutic target[5]. Like other lincRNAs, it is presumed to be involved in modulating gene expression or chromatin structure, but further experimental research is needed to define its biological roles[3][1].

Other names
LINC01364Long Intergenic Non-Protein Coding RNA 1364
02

Mechanism of action

None reported (no established drug interactions)

03

Biological functions

Other (Potentially regulatory non-coding RNA; specific biological functions have not been conclusively established for LINC01364. See description.)
04

Disease associations

Other (No direct, established roles in disease such as cancer, inflammation, or neurodegenerative disease currently reported for LINC01364.)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1364 (LINC01364).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1364 (LINC01364).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call